Pharmadrug Inc.
PHRX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -255.70K | -554.50K | -9.65M | -9.74M | -9.95M |
| Total Depreciation and Amortization | 36.20K | 36.70K | 47.00K | 37.80K | 28.60K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 4.40K | 16.50K |
| Total Other Non-Cash Items | 170.50K | 181.20K | 9.02M | 9.00M | 9.01M |
| Change in Net Operating Assets | -116.70K | -222.10K | -188.40K | -182.40K | 63.40K |
| Cash from Operations | -166.00K | -558.90K | -773.60K | -885.00K | -832.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 545.10K | 545.10K | 545.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.60K | -8.60K | -200.00 | 5.80K | 34.00K |
| Cash from Investing | -8.60K | -8.60K | 544.80K | 550.80K | 579.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 100.00K |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | 326.00K | 326.00K | 326.00K | 326.00K |
| Repurchase of Common Stock | -91.60K | -91.60K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.20K | 87.20K | -51.10K | 248.90K | 242.10K |
| Cash from Financing | -3.20K | 238.60K | 204.20K | 427.90K | 497.20K |
| Foreign Exchange rate Adjustments | -1.70K | -1.70K | 600.00 | 1.30K | 1.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -179.40K | -330.50K | -24.00K | 95.00K | 245.80K |